ISB News

For the first time in the U.S.: Join ISB for BIO-FICTION

Join us on Thursday, May 7
at Institute for Systems Biology 
in South Lake Union

Doors open at 4:30pm. Screening begins at 5:00pm, followed by a panel discussion.

BIO·FICTION explores the emerging field of synthetic biology from different disciplinary angles including science and engineering, social science, cultural studies, amateur biology, film making, art and design. The original program had presentations, panel discussions, do-it-yourself biology demos, performances, art works and, of course, film screenings. It featured short films on any aspect of synthetic biology, including documentary films, animation, and science fiction. BIO·FICTION was created by Markus Schmidt and Camillo Meinhart and was held in Vienna in 2011 and again in 2014. Institute for Systems Biology (ISB) is the first organization to share the event in the United States.

The screening is free and happening in conjunction to South Lake Union Art Walk. Reserve your spot!

RSVP

 

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.